TRAVELERS COMPANIES, INC.·4

Feb 27, 4:12 PM ET

Rowland David Donnay 4

4 · TRAVELERS COMPANIES, INC. · Filed Feb 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Travelers (TRV) EVP David Donnay Exercises Options and Sells Shares

What Happened
David Donnay, Executive Vice President & Co‑Chief Investment Officer of Travelers Companies (TRV), exercised 4,731 derivative shares and immediately sold those 4,731 shares on Feb 26, 2026. He paid $126.18 per share on the exercise (cost $596,958) and sold at an average price of $308.52 per share for total proceeds of $1,459,604 — net proceeds before fees/taxes of roughly $862,646. The filing shows the exercise/conversion and the contemporaneous open‑market sale.

Key Details

  • Transaction date: 2026-02-26 (Form 4 filed 2026-02-27 — timely)
  • Exercise: 4,731 shares at $126.18 each (total cost $596,958) — code M (derivative exercise)
  • Sale: 4,731 shares at weighted avg $308.52 (total proceeds $1,459,604) — code S
  • Footnote: Weighted avg sale price represents prices ranging $308.18–$308.62; reporter can provide breakdown on request (F1)
  • Shares owned after transaction: Not disclosed in this Form 4
  • No 10b5‑1 plan, tax‑withholding, or late‑filing indication shown in the filing

Context
This was a cashless exercise pattern: options/derivative were exercised and the resulting shares were sold the same day. The filing also includes a derivative conversion/ disposition line at $0.00, which reflects the option conversion/cancellation reporting tied to the exercise. Such immediate sales are common for option exercises to cover the exercise cost and taxes and do not by themselves indicate a change in long‑term insider sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-26
Rowland David Donnay
EVP & Co-Chief Invest. Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-26$126.18/sh+4,731$596,95815,209.629 total
  • Sale

    Common Stock

    [F1]
    2026-02-26$308.52/sh4,731$1,459,60410,478.629 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2026-02-264,7310 total
    Exercise: $126.18From: 2022-02-05Exp: 2029-02-05Common Stock (4,731 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    5,881.556
  • Common Stock

    (indirect: By Trust)
    22,083
Footnotes (1)
  • [F1]Represents the weighted average sales price for increments ranging from $308.18 to $308.62. The Reporting Person undertakes to provide upon request by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Signature
/s/Wendy C. Skjerven, by power of attorney|2026-02-27

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT